AF
RCEL icon

Amalgamated Financial’s Avita Medical RCEL Stock Holding History

Amalgamated Financial’s Portfolio RCEL Stock Details RCEL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		$34K Buy
+3,967
New +$36.6K ﹤0.01% 2579

Other funds holding RCEL

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
PVI
Pura Vida Investments New York $14.9M AUM 38.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

Amalgamated Financial's RCEL Position: Q1 2022 in Review

Amalgamated Financial opened a new position in Avita Medical (RCEL) in Q1 2022: 3,967 shares worth $34K. The stake represents ﹤0.01% of the portfolio and ranks #2579 among its holdings.

69 funds tracked by Wall St. Rank hold RCEL as of Q1 2022.

  • Amalgamated Financial held 3,967 shares of Avita Medical worth $34K as of Q1 2022.
  • Avita Medical was a new Amalgamated Financial position in Q1 2022.
  • Avita Medical made up ﹤0.01% of Amalgamated Financial's portfolio in Q1 2022, its #2579 holding.
  • 69 funds tracked by Wall St. Rank held Avita Medical as of Q1 2022.

Based on Amalgamated Financial's 13F filing for Q1 2022, filed 16 May 2022.